Rating Change
JP Morgan reiterated its Neutral rating on HCA Healthcare, Inc. (NYSE:HCA) on August 20, 2026.
reiterateNYSE:HCA
JP Morgan Reiterates Neutral Rating on HCA Healthcare, Inc. (HCA)
JP Morgan reiterated its Neutral rating on HCA Healthcare, Inc. (NYSE:HCA) on August 20, 2026.
At publication ·
What changed
HCA Healthcare, Inc. (NYSE:HCA) · reiterate
- Firm
- JP Morgan
- Rating
- Neutral to Neutral
- Price at event
- $406.27
- Market capitalization
- $117.1B
At a glance
Key takeaways
- JP Morgan reiterated a Neutral rating on HCA Healthcare on August 20, 2026, with the stock trading at $406.27 and a market capitalization of $117.1 billion.
Market Context
HCA Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $406.27 with a market capitalization of $117.1B. The stock has declined 20.1% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for HCA Healthcare, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for HCA Healthcare, Inc.
Among the 10 most recent ratings: 7 Buy, 2 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | JP Morgan | Neutral | N/A |
| Aug 03, 2026 | Wells Fargo | Equal-Weight | N/A |
| Jul 28, 2026 | Goldman Sachs | Buy | N/A |
| Jul 28, 2026 | Mizuho | Outperform | N/A |
| Jul 27, 2026 | Morgan Stanley | Underweight | N/A |
Related Tools: Analyst Ratings Dashboard | View HCA Stock Page
Frequently Asked Questions
What does the Neutral rating mean for HCA?
A rating of Neutral from JP Morgan reflects the analyst's outlook on HCA Healthcare, Inc. (NYSE:HCA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HCA forecast page.
